Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fascia Iliaca Block vs Dexmedetomidine/Ketamine for Positioning in Femur Fracture
NCT05705726Unknown
- Sponsor
- Minia University
- Start
- Feb 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection, dexmedetomidine and ketamine in procedural pain (2 arms), sponsored by Minia University. Primary endpoint: Behavioral Pain Scale. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injectiondexmedetomidineketamine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT05705726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705726.